Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact

Originally published as JHC exPRESS on April 16, 2007.
doi:10.1369/jhc.7A7185.2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jhc.7A7185.2007v1
55/9/877    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chalabi, N.
Right arrow Articles by Bernard-Gallon, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chalabi, N.
Right arrow Articles by Bernard-Gallon, D. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry
Volume 55 (9): 877-883, 2007
Copyright ©The Histochemical Society, Inc.

Immunohistochemical Expression of RAR{alpha}, RARß, and Cx43 in Breast Tumor Cell Lines After Treatment With Lycopene and Correlation With RT-QPCR

Nasséra Chalabi, Laetitia Delort, Samir Satih, Pierre Déchelotte, Yves-Jean Bignon and Dominique J. Bernard-Gallon

Département d'Oncogénétique, Centre Jean Perrin, Clermont-Ferrand, France (NC,LD,SS,Y-JB,DJB-G); INSERM UMR 484, Clermont-Ferrand, France (NC,LD,SS,Y-JB,DJB-G); Centre de Recherche en Nutrition Humaine, Clermont-Ferrand, France (NC,LD,SS,Y-JB,DJB-G); Anatomie Pathologique, Hôtel Dieu, Clermont-Ferrand, France (PD); and Université d'Auvergne, Clermont-Ferrand, France (PD,Y-JB)

Correspondence to: Pr Yves-Jean Bignon, Département d’Oncogénétique, Centre Jean Perrin, UMR 484 INSERM-UdA, 58 Rue Montalembert, BP 392, 63011 Clermont-Ferrand Cedex 1, France. E-mail: Yves-Jean.BIGNON{at}cjp.fr


   Summary
Top
 Summary
Introduction
 Materials and Methods
 Results
 Discussion
 Literature Cited
 
Lycopene, the major carotenoid found in tomatoes, is a potent antioxidant associated with the prevention of degenerative diseases such as breast cancer. This effect could be due to the interaction between lycopene and retinoic acid receptors as well as the stimulation of gap junction communication and synthesis of connexin 43. The expression of the RAR{alpha}, RARß, and Cx43 proteins was analyzed using immunohistochemistry in two breast cancer cell lines, MCF-7 and MDA-MB-231, and in a fibrocystic dystrophy cell line, MCF-10a, after a 48-hr exposure to 10 µM lycopene. A real-time quantitative PCR analysis was then performed to measure mRNA expression. RAR{alpha} and Cx43 expression were increased at both mRNA and protein levels in two breast cell lines. (J Histochem Cytochem 55:877–883, 2007)

Key Words: lycopene • breast cancer cell lines • immunohistochemistry • RT-QPCR • RAR{alpha} • RARß • Cx43


   Introduction
Top
 Summary
 Introduction
Materials and Methods
 Results
 Discussion
 Literature Cited
 
THIS WORK EVALUATED THE IMPACT OF LYCOPENE, which is abundant in tomatoes and related products, on the development of breast cancer. Lycopene is one of the carotenoids thought to have a potential effect on human health, notably against chronic diseases such as cancer and cardiovascular disease. Its anticarcinogenic properties are essentially due not only to its antioxidant effect but also to its capacity to increase gap-junctional intercellular communication (GJIC) and to inhibit tumor cell proliferation (Bertram et al. 1991Go; Zhang et al. 1991Go). Lycopene was reported to induce a G1/S cell cycle arrest in the MCF-7 breast cancer cell line by decreasing the expression of the D1 and D3 cyclins, which are expressed at a high level in breast cancer (Nahum et al. 2001Go). Furthermore, lycopene upregulates connexin 43 (Cx43) gene expression and enhances GJIC, which occurs at an early stage of carcinogenesis (Zhang et al. 1991Go,1992Go). The present study was therefore undertaken to compare the expression and distribution of the retinoic acid receptor isoforms RAR{alpha} and RARß, and of Cx43, which is the major connexin expressed in breast tissue in the presence and absence of lycopene, using immunohistochemistry and real-time quantitative PCR (RT-QPCR) in the MCF-7 and MDA-MB-231 cell lines and the MCF-10a fibrocystic dystrophy cell line.


   Materials and Methods
Top
 Summary
 Introduction
 Materials and Methods
Results
 Discussion
 Literature Cited
 
Cell Lines
MCF-7 and MDA-MB-231 cells (American Type Culture Collection), originating from a pleural effusion of patients with invasive breast carcinoma (Soule et al. 1973Go; Cailleau et al. 1974Go), were grown, respectively, in RPMI 1640 medium supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 20 µg/ml gentamycin, and 0.04 U/ml insulin; and L-15 Leibovitz medium (Invitrogen SARL; Cergy Pontoise, France) supplemented with 2 mM L-glutamine, 20 µg/ml gentamycin and 15% heat-inactivated FBS. For experiments, cells were grown in T-75 flasks to a density of 106 cells in 15 ml of medium at 37C in a humidified atmosphere, with 5% CO2 for MCF-7 and without CO2 for MDA-MB-231.

The MCF-10a cell line was established from the mammary tissue of a patient with fibrocystic breast disease (Soule et al. 1990Go). Cells were grown in DMEM/Ham's F12 (Invitrogen SARL) with 20 ng/ml epidermal growth factor, 100 ng/ml cholera toxin, 0.01 mg/ml insulin, 500 ng/ml hydrocortisone, and 10% heat-inactivated horse serum. Cells were grown in a 37C humidified atmosphere with 5% CO2.

Lycopene Treatment
Exposure to lycopene was carried out for 48 hr with 10 µM synthetic lycopene dissolved in 0.25 g/l tetra hydro furane-butylated hydroxyl toluene (Sigma Chimie; St Quentin Fallavier, France). This concentration was previously reported (Chalabi et al. 2004Go) to induce a G1/S-phase cell cycle arrest with an increase in late-G1 phase cell number. Control cells were plated in medium without lycopene supplementation.

Immunohistochemistry
Four-µm alcohol-formalin-acetic acid–fixed and paraffin-embedded sections were cut using a microtome, mounted on silanized glass slides (Starfrost; Duiven, The Netherlands), and dried overnight at 37C. After deparaffinization and rehydration through graded alcohols (100% and 70%) and distilled water, a heat-induced antigen retrieval method was used, which included a 3-min incubation in citrate buffer, pH 5.95, in a pressure cooker, followed by a 15-min cooldown period in a water bath. Further processing was performed with a NexES automated immunostainer using an AEC kit (Ventana Medical Systems Inc.; Tucson, AZ). Slides were then incubated at 37C for 32 min with anti-RAR{alpha} (rabbit, sc-5051; Santa Cruz Biotechnology, Santa Cruz, CA), anti-RARß (rabbit, sc-552; Santa Cruz Biotechnology), or anti-Cx43 (rabbit, sc-909, goat, sc-6560; Santa Cruz Biotechnology) primary antibodies. All antibodies were used at a 1:10 dilution except for rabbit anti-Cx43, which was used at 1:5. Subsequent incubations with a biotinylated secondary antibody, avidin-conjugated peroxidase complex, were carried out in a Ventana NexES immunostainer in accordance with the manufacturer's protocol. Slides were then counterstained with hematoxylin for 3 min, rinsed in distilled water, and coverslipped with an aqueous Faramount mounting media (DAKO; Glostrup, Denmark). The primary polyclonal antibody was omitted and replaced with PBS as a negative control.

RT-QPCR
RNA Extraction
Cells were plated at a density of 3 x 106 cells per T-75-cm2 flasks. At 80% confluence, cells were washed twice with PBS. Total RNA was isolated using 1 ml of RNA-B (Qbiogene; Illkirch, France) according to the manufacturer's protocol. Total RNA samples were dissolved in diethyl-pyrocarbonate–treated water, and A260 measurements were performed to determine their concentrations using a Hitachi spectrophotometer U-2000.

Microchip Gel Electrophoresis
The Agilent 2100 Bioanalyzer and RNA 6000 Nano LabChip kit (Agilent Biotechnologies; Palo Alto, CA) were used to assess the RNA quality of tissue samples. RNA samples were diluted, and 1 µl [which corresponds to ~1.5% (v/v) of each probe] was transferred to the Nano LabChip along with 1 µl of RNA 6000 ladder (Ambion; Courtaboeuf, France). Analyses were performed according to the manufacturer's instructions, and results were shown as electropherograms.

cDNA Synthesis
One µg of total RNA was used for the synthesis of first-strand cDNA using the First Strand cDNA Synthesis kit (Amersham Pharmacia Biotech; Uppsala, Sweden) following the manufacturer's instructions.

RT-QPCR
mRNA levels were quantified using an ABI Prism 7700 Sequence Detection System (Applied Biosystems; Courtaboeuf, France) and Assay-on-Demand (Applied Biosystems), except for the 18S and Cx43 genes. 18S and Cx43 probes and primers were designed so that they overlapped splice junctions, thereby avoiding the potential amplification of genomic DNA. Sequences were chosen using Primer Express (Applied Biosystems) software and are presented in Table 1 .


View this table:
[in this window]
[in a new window]

  		Table 1

Sequences of Assay-on-Demand, primers, and Taqman probes used for the quantification of RAR{alpha}, RARß, Cx43, and 18S transcripts

 
Twenty-five ng of cDNA was used in the RT-QPCR for mRNA expression in a total volume of 25 µl reaction mixture containing 12.5 µl TaqMan Universal PCR Master Mix (2x). The mix was optimized for 5' nuclease assay using TaqMan probes and contained AmpliTaq Gold DNA Polymerase, AmpErase uracil-DNA glycosylase, and desoxyribonucleotide triphosphates with 2'-desoxyuridine 5'-triphosphate. Two-hundred nM of RAR{alpha} or RARß Assay-on-Demand, or 50 nM Cx43 and 18S primers and TaqMan probes were added. Amplification reactions were performed by a three-step thermal cycling method, which consisted of a 2-min step at 50C and 10 min at 95C followed by 40 cycles at 95C for 30 sec and 60C for 1 min. RT-QPCR assays were conducted in quadruplicate for each sample. Relative quantitation of mRNA level was done using the comparative CT method (Fink et al. 1998Go), which is the quantitative normalization of cDNA in each sample to an internal control (i.e., 18S rRNA) to normalize quantity and quality of cDNA samples. To ensure the reproducibility of mRNA determinations, two independent total RNA extractions were performed. Two independent reverse transcription reactions were carried out for one RNA extraction, whereas only one was performed for the second extraction. Each RT was analyzed in triplicate and expressed as a mean value ± standard deviation (Favy et al. 2000Go).


   Results
Top
 Summary
 Introduction
 Materials and Methods
 Results
Discussion
 Literature Cited
 
Immunohistochemistry
Expression patterns of RAR{alpha}, RARß, and Cx43 appeared heterogeneous among the breast cell lines studied. Major differences emerged in nuclear and cytoplasmic localizations (Table 2 ).


View this table:
[in this window]
[in a new window]

  		Table 2

RAR{alpha}, RARß, and Cx43 immunostaining in MCF-7, MDA-MB-231, and MCF-10a breast cell lines upon a 48-hour exposure to 10 µM lycopene

 
MCF-7 Cell Line
In the estrogen-positive MCF-7 breast cancer cell line, patterns for RAR{alpha} and RARß retinoic acid receptors displayed a cytoplasmic staining that was increased in lycopene-treated cells (Figures 1A and 1B). Nuclear expression and moderate Cx43 cytoplasmic expression were observed in control cells. After lycopene exposure, a nuclear expression was observed along with an increase in gap junctions (data not shown).


Figure 1
View larger version (131K):
[in this window]
[in a new window]

  		Figure 1

In MCF-7 cells: (A) RAR{alpha} expression showing a cytoplasmic staining in control cells, which was increased upon a 48-hr exposure to 10 µM lycopene. (B) RARß expression pattern showing a strong increase in cytoplasmic staining upon exposure to lycopene.

 
MDA-MB-231 Cell Line
A 48-hr exposure to 10 µM lycopene increased nuclear RAR{alpha} expression in membranes along with the appearance of herniæ (Figure 2A ). In contrast, a high RARß staining that was stronger in the presence of 10 µM lycopene for 48 hr was found in control cytoplasms (Figure 2B). No Cx43 staining was observed in control cells, but lycopene treatment resulted in an intense Cx43 expression in hernia on membrane (Figure 2C).


Figure 2
View larger version (103K):
[in this window]
[in a new window]

  		Figure 2

In MDA-MB-231 cells: (A) No RAR{alpha} expression was observed in control cells, whereas a nuclear staining was revealed upon exposure to lycopene. (B) Increase in RARß cytoplasmic expression upon lycopene supplementation. (C) Increase in connexin 43 staining upon lycopene treatment, with the appearance of herniæ.

 
MCF-10a Cell Line
In the MCF-10a fibrocystic dystrophy cell line, a moderate RAR{alpha} cytoplasmic expression was observed in control cells. Upon lycopene treatment, this intensity increased moderately within the cytoplasm and the membrane (data not shown). A strong RARß staining that increased within the nucleus of lycopene-treated cells was revealed in the nucleus and cytoplasm of control cells (Figure 3A ). A moderate Cx43 staining that increased sharply after lycopene treatment was found on the membrane of control cells (Figure 3B).


Figure 3
View larger version (66K):
[in this window]
[in a new window]

  		Figure 3

In MCF-10a cells: (A) Increase in RARß staining within the nucleus and the cytoplasm. (B) Increase in connexin 43 expression in lycopene-treated cells.

 
RT-QPCR
To quantify RAR{alpha}, RARß, and Cx43 mRNA expression upon exposure to lycopene, an RT-QPCR study using the Taqman method was performed in MCF-7, MDA-MB-231, and MCF-10a breast cell lines (Figure 4 ). Expression of each mRNA species in lycopene-treated cells was normalized to their expression level in control cells, which was set to the arbitrary value of 1.


Figure 4
View larger version (13K):
[in this window]
[in a new window]

  		Figure 4

Quantitative RT-PCR of RAR{alpha}, RARß, and Cx43 mRNA in the MCF-7 (A), MDA-MB-231 (B), and MCF-10a (C) breast cell lines upon a 48-hr treatment with 10 µM lycopene. Expression in treated cells was normalized to untreated controls (corresponding to the arbitrary value of 1). Each measurement was performed on the product of two extractions and three reverse transcription reactions and was expressed as mean value ± standard deviation. Statistical analysis was performed using the Student's t-test (* p<0.05; ** p<0.01).

 
Lycopene significantly increased RAR{alpha} mRNA expression in MCF-7 (p<0.05) and MCF-10a (p<0.01) cells. However, no variation in RAR{alpha} mRNA expression was observed in MDA-MB-231 cells. Although an increase in RARß mRNA levels in MDA-MB-231 cells (p<0.01) was measured, a decrease was shown in MCF-7 and MCF-10a cells. Lycopene treatment resulted in a significant increase in Cx43 mRNA levels in MDA-MB-231 and MCF-10a (p<0.01), but no variation was obtained in the MCF-7 cell line.


   Discussion
Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
Literature Cited
 
In this work, we performed an immunohistochemical study of RAR{alpha}, RARß, and Cx43, which are three markers potentially involved in breast cancer in three breast cell lines (MCF-7, MDA-MB-231, and MCF-10a), upon exposure to 10 µM lycopene for 48 hr. This concentration was previously reported to induce a G1/S cell cycle arrest, during which BRCA1 and BRCA2 were highly expressed (Chalabi et al. 2004Go).

The present results showed heterogeneous expression patterns among these cell lines. Immunohistochemical expression of RAR{alpha} indeed demonstrated a cytoplasmic staining in the MCF-7 and MCF-10a cell lines, which increased upon exposure to lycopene. In contrast, no expression was found in MDA-MB-231 control cells, whereas a nuclear staining was observed upon exposure to lycopene, with a high expression within herniæ on membranes. These results were consistent with those obtained using RT-QPCR. While the RARß cytoplasmic staining in MCF-7 and MDA-MB-231 increased upon a 48-hr exposure to 10 µM lycopene, a nuclear RARß staining that increased after exposure to lycopene was observed in the MCF-10a dystrophic cell line. In contrast, RT-QPCR experiments showed a decrease in RARß mRNA expression in MCF-7 and MCF-10a cell lines. An inverse relationship was previously found between mRNA and protein expressions for BRCA1 and BRCA2 genes (Chalabi et al. 2004Go). These results were due to posttranscriptional and posttranslational modifications. Although no variation was observed for BRCA1 and BRCA2 proteins upon exposure to lycopene, increased levels of phosphorylated BRCA1 and BRCA2 proteins were observed (Chalabi et al. 2005Go). It would therefore be of interest to assess the phosphorylation status of RARß protein, along with its acetylation or ubiquitination levels. RAR{alpha} plays a major role in retinoid-mediated growth inhibition of human breast cancer cells in vitro. Moreover, RAR{alpha} protein was reported to be expressed at significantly higher levels in tumors with greater proliferative activity, suggesting that RAR{alpha} expression may be altered with tumor progression (van der Leede et al. 1996Go). It has been established that RAR{alpha} expression is greater in estrogen receptor (ER)-positive cell lines, whereas RARß is more commonly expressed in ER-negative cell lines (Roman et al. 1992Go). Furthermore, in the ER-positive MCF-7 cell line, RAR{alpha} levels were about twice as high as in ER-negative MDA-MB-231 cells (Han et al. 1997Go), which could account for the lack of expression of RAR{alpha} observed in the untreated ER{alpha}-negative MDA-MB-231 cell line. These data were consistent with results reported by Lu et al. (2005)Go, in which ER{alpha} and RAR{alpha} protein levels were compared in five breast cancer cell lines, including MCF-7 and MDA-MB-231; ER{alpha} and RAR{alpha} were expressed in MCF-7 cells but not in MDA-MB-231 cells (Lu et al. 2005Go). Moreover, ER{alpha} has been shown to be a direct regulator of RAR{alpha} transcription, and an estrogen response element was identified in the RAR{alpha} promoter (Roman et al. 1993Go; Rishi et al. 1995Go; van der Leede et al. 1995Go; Han et al. 1997Go; Lu et al. 2005Go).

Previous studies reported that lycopene enhances GJIC (Bertram et al. 1991Go; Zhang et al. 1991Go; Sies and Stahl 1998Go; Aust et al. 2003Go). Loss of GJIC is one of the hallmarks of carcinogenesis (Yamasaki et al. 1995Go,1996Go) and its restoration or upregulation is associated with decreased proliferation (Heber and Lu 2002Go). In this work, we studied the expression of Cx43 in breast cell lines upon a 48-hr exposure to 10 µM lycopene by immunohistochemistry. Cx43 was indeed thought to be a relevant marker of early oncogenesis in breast tissue (Laird et al. 1999Go). Moreover it has been demonstrated that carotenoids, including lycopene, upregulate Cx43 at both protein and mRNA levels (Zhang et al. 1992Go). Our results showed a nuclear and cytoplasmic pattern of Cx43 expression in the MCF-7 cell line and an increase in gap junctions upon lycopene supplementation. No Cx43 expression was observed in untreated MDA-MB-231 cells, whereas lycopene-treated MDA-MB-231 cells showed a positive pattern in nuclear membranes and hernia. A slight positive pattern that was significantly increased upon exposure to lycopene was observed on the membrane of MCF-10a control cells. RT-QPCR experiments confirmed immunohistochemistry results. Several studies have shown expression of connexins in tumor cells, but these have been abnormally located and accumulated within the cytoplasm. Such observations have been made both in vitro and in vivo and did not depend on the origin of the tumor (Mesnil et al. 2005Go). It has been demonstrated that relocation of Cx43 to the membrane is associated with the induction of GJIC and decreased cell growth in vitro (Roger et al. 2004Go). The relationship between the Cx43 location on the membrane and growth regulation could be associated with the phosphorylation of Cx43, which would result in the cytoplasmic location to the endosomes through the activation of the extracelular signal-regulated kinase/mitogen-activated protein kinase pathway (Mograbi et al. 2003Go).

In conclusion, this study suggests a putative role for lycopene in RAR and Cx43 expression in breast cell lines. Tomato consumption has been demonstrated in vitro and in clinical studies to have beneficial and protective effects with regard to degenerative diseases such as cancer. Its mechanism of action, however, is not totally clear. Our results would suggest a possible action of lycopene in breast cancer cell lines via retinoic acid receptors. Further investigations are nevertheless necessary to identify other molecular pathways to evaluate their possible biological relevance.


   Acknowledgments
 
This work was supported by grants from La Ligue Nationale Française de Lutte Contre le Cancer and Le Comité du Puy-de-Dôme. N.C. is the recipient of a grant from the Fondation pour la Recherche Médicale; L.D. is the recipient of a grant from the Association pour la Recherche sur le Cancer; S.S. is the recipient of a grant from the Département d'Oncogénétique of Centre Jean Perrin.

We are grateful to Christelle Picard and Jacqueline Avinain for their technical assistance, and to Stéphanie Arnould for correcting the English.


   Footnotes
 
Received for publication January 11, 2007; accepted March 29, 2007


   Literature Cited
Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
 Literature Cited
 

Aust O, Ale-Agha N, Zhang L, Wollersen H, Sies H, Stahl W (2003) Lycopene oxidation product enhances gap junctional communication. Food Chem Toxicol 41:1399–1407[CrossRef][Medline]

Bertram JS, Pung A, Churley M, Kappock TJ IV, Wilkins LR, Cooney RV (1991) Diverse carotenoids protect against chemically induced neoplastic transformation. Carcinogenesis 12:671–678[Abstract/Free Full Text]

Cailleau R, Young R, Olive M, Reeves WJ Jr (1974) Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53:661–674[Medline]

Chalabi N, Le Corre L, Maurizis JC, Bignon YJ, Bernard-Gallon DJ (2004) The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression. Eur J Cancer 40:1768–1775[CrossRef][Medline]

Chalabi N, Maurizis JC, Le Corre L, Delort L, Bignon YJ, Bernard-Gallon DJ (2005) Quantification by affinity perfusion chromatography of phosphorylated BRCAl and BRCA2 proteins from tumor cells after lycopene treatment. J Chromatogr B Analyt Technol Biomed Life Sci 821:188–193[CrossRef][Medline]

Favy DA, Lafarge S, Rio P, Vissac C, Bignon YJ, Bernard-Gallon D (2000) Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines. Biochem Biophys Res Commun 274:73–78[CrossRef][Medline]

Fink L, Seeger W, Ermert L, Hanze J, Stahl U, Grimminger F, Kummer W, et al. (1998) Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 4:1329–1333[CrossRef][Medline]

Han QX, Allegretto EA, Shao ZM, Kute TE, Ordonez J, Aisner SC, Rishi AK, et al. (1997) Elevated expression of retinoic acid receptor-alpha (RAR alpha) in estrogen-receptor-positive breast carcinomas as detected by immunohistochemistry. Diagn Mol Pathol 6:42–48[CrossRef][Medline]

Heber D, Lu QY (2002) Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood) 227:920–923[Abstract/Free Full Text]

Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA (1999) Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res 59:4104–4110[Abstract/Free Full Text]

Lu M, Mira-y-Lopez R, Nakajo S, Nakaya K, Jing Y (2005) Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells. Oncogene 24:4362–4369[CrossRef][Medline]

Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML (2005) Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 1719:125–145[Medline]

Mograbi B, Corcelle E, Defamie N, Samson M, Nebout M, Segretain D, Fenichel P, et al. (2003) Aberrant connexin 43 endocytosis by the carcinogen lindane involves activation of the ERK/mitogen-activated protein kinase pathway. Carcinogenesis 24:1415–1423[Abstract/Free Full Text]

Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y (2001) Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene 20:3428–3436[CrossRef][Medline]

Rishi AK, Shao ZM, Baumann RG, Li XS, Sheikh MS, Kimura S, Bashirelahi N, et al (1995) Estradiol regulation of the human retinoic acid receptor alpha gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res 55:4999–5006[Abstract/Free Full Text]

Roger C, Mograbi B, Chevallier D, Michiels JF, Tanaka H, Segretain D, Pointis G, et al. (2004) Disrupted traffic of connexin 43 in human testicular seminoma cells: overexpression of Cx43 induces membrane location and cell proliferation decrease. J Pathol 202:241–246[CrossRef][Medline]

Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RL (1992) Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 52:2236–2242[Abstract/Free Full Text]

Roman SD, Ormandy CJ, Manning DL, Blamey RW, Nicholson RI, Sutherland RL, Clarke CL (1993) Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res 53:5940–5945[Abstract/Free Full Text]

Sies H, Stahl W (1998) Lycopene: antioxidant and biological effects and its bioavailability in the human. Proc Soc Exp Biol Med 218:121–124[Abstract]

Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, et al. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075–6086[Abstract/Free Full Text]

Soule HD, Vazguez J, Long A, Albert S, Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409–1416[Medline]

van der Leede BJ, Folkers GE, van den Brink CE, van der Saag PT, van der Burg B (1995) Retinoic acid receptor alpha 1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol Cell Endocrinol 109:77–86[CrossRef][Medline]

van der Leede BM, Geertzema J, Vroom TM, Decimo D, Lutz Y, van der Saag PT, van der Burg B (1996) Immunohistochemical analysis of retinoic acid receptor-alpha in human breast tumors: retinoic acid receptor-alpha expression correlates with proliferative activity. Am J Pathol 148:1905–1914[Abstract]

Yamasaki H, Krutovskikh V, Mesnil M, Omori Y (1996) Connexin genes and cell growth control. Arch Toxicol Suppl 18:105–114[Medline]

Yamasaki H, Mesnil M, Omori Y, Mironov N, Krutovskikh V (1995) Intercellular communication and carcinogenesis. Mutat Res 333:181–188[CrossRef][Medline]

Zhang LX, Cooney RV, Bertram JS (1991) Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 12:2109–2114[Abstract/Free Full Text]

Zhang LX, Cooney RV, Bertram JS (1992) Carotenoids up-regulate connexin43 gene expression independent of their provitamin A or antioxidant properties. Cancer Res 52:5707–5712[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jhc.7A7185.2007v1
55/9/877    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chalabi, N.
Right arrow Articles by Bernard-Gallon, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chalabi, N.
Right arrow Articles by Bernard-Gallon, D. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact